Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Lidocaine for Pain Relief After Thyroidectomy
NCT01608360Phase 4
Key facts
- Status
- Unknown
- Start
- Jul 2011
- Primary completion
- Dec 2014
- Countries
- 1
- Sponsor
- Chung-Ang University Hospital
- Conditions
- postoperative pain
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Intravenous lidocaine injection group with Placebo control group (2 arms). Primary endpoint: Visual Analogue Scale at 2 hours. Status: unknown.
02
Design
2 arms- Study design
- RandomizedDouble-blind
Intravenous lidocaine injection group
Patients receive IV lidocaine bolus and continuous infusion.
Placebo control group
Patients receive IV normal saline.
03
Who it enrols
Patients aged 18-65 undergoing total thyroidectomy, excluding those with mental changes or allergies to local anesthetics.
04
Endpoints
Primary
Visual Analogue Scale at 2 hours
Secondary
Visual Analogue Scale at 4 hours
Visual Analogue Scale at 8 hours
Visual Analogue Scale at 12 hours
Visual Analogue Scale at 24 hours
Visual Analogue Scale at 48 hours
Opioid consumption at 2 hours
Opioid consumption at 4 hours
Opioid consumption at 8 hours
Beyond the preview
Go deeper on NCT01608360.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01608360.